Professor Liu xinhui’s research primarily focuses on the Jian-Pi-Yi-Shen Formula (JPYSF), which effectively improves renal function and structure in CKD rats through various mechanisms such as modulating the mitochondrial quality control network, tryptophan metabolism, aryl hydrocarbon receptor signaling, renal glucose metabolism pathways, and by activating SIRT3 and enhancing antioxidant effects (37–40). Here, AHR is linked to chronic kidney disease.